FIELD: medicine.
SUBSTANCE: invention relates to medicine and relates to a method for treating male infertility in the form of idiopathic oligospermia, oligozoospermia, with the exception of gross oligozoospermia with a sperm concentration of less than 5 million/ml and/or asthenozoospermia. The essence of the method lies in the fact that the patient is injected with a selective alpha1-blocker 10 mg/day together with a complex of nutrients, including carnitines 2000-3000 mg/day, vitamin E 25-200 ME/day, vitamin D3 500 ME/day, zinc 5- 40 mg/day for at least 12 weeks.
EFFECT: allows to increase the effectiveness of therapy for idiopathic male infertility in the form of oligospermia, oligozoospermia and/or asthenozoospermia.
1 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR LABORATORY DIAGNOSIS OF MALE REPRODUCTIVE FUNCTION BASED ON EVALUATION OF SPERMATOZOA DNA FRAGMENT DISPERSION | 2022 |
|
RU2795567C1 |
MALE REPRODUCTIVE FUNCTION TEST METHOD | 2023 |
|
RU2819094C1 |
METHOD OF TREATING MALE INFERTILITY | 2020 |
|
RU2738543C2 |
METHOD OF IMPROVEMENT OF SPERMATOZOON MOTILITY | 1998 |
|
RU2167675C2 |
METHOD OF PREDICTION OF IDIOPATHIC MALE INFERTILITY BASED ON ANALYSIS OF NUCLEOTIDE VARIANTS IN MITOCHONDRIAL CYTOCHROME B GENE | 2022 |
|
RU2800406C1 |
METHOD OF INFERTILITY DIAGNOSTICS FOR MEN | 2008 |
|
RU2371720C1 |
METHOD FOR ASSESSING THE REPRODUCTIVE FUNCTION IN MEN WITH IDIOPATHIC INFERTILITY | 2021 |
|
RU2759147C1 |
METHOD OF TREATING MALE STERILITY CAUSED BY AUTOIMMUNE RESPONSE TO SPERM CELLS | 2012 |
|
RU2517061C1 |
METHOD FOR PREDICTION OF PREGNANCY IN SUBFERTILE MALES AFTER VARICOCELECTOMY | 2023 |
|
RU2823112C1 |
METHOD FOR TREATING AUTOIMMUNE MALE INFERTILITY CASES | 2005 |
|
RU2294779C1 |
Authors
Dates
2021-10-18—Published
2020-07-20—Filed